BlackRock, Inc. 13D and 13G filings for 10x Genomics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-31 2:08 pm Purchase | 2023-12-31 | 13G | 10x Genomics, Inc. TXG | BlackRock Inc. BLK | 5,705,051 5.500% | 385,872 (+7.25%) | Filing |
| 2023-02-01 4:54 pm Purchase | 2022-12-31 | 13G | 10x Genomics, Inc. TXG | BlackRock Inc. BLK | 5,319,179 5.600% | 327,892 (+6.57%) | Filing |
| 2022-08-09 4:02 pm Sale | 2022-07-31 | 13G | 10x Genomics, Inc. TXG | BlackRock Inc. BLK | 4,991,287 5.300% | -5,236,386 (-51.20%) | Filing |
| 2022-05-09 3:23 pm Purchase | 2022-04-30 | 13G | 10x Genomics, Inc. TXG | BlackRock Inc. BLK | 10,227,673 10.900% | 2,209,039 (+27.55%) | Filing |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | 10x Genomics, Inc. TXG | BlackRock Inc. BLK | 8,018,634 8.800% | 2,855,614 (+55.31%) | Filing |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | 10x Genomics, Inc. TXG | BlackRock Inc. BLK | 5,163,020 6.400% | 5,163,020 (New Position) | Filing |